| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Dyes & Pigments
|
Compare with Industry peers |
| Website | http://www.genpharmasec.com | |
| Market Cap | 88.32 Cr. | |
| Enterprise Value(EV) | 83.87 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.00 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 689.99 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 20.96 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 0.56 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 5.71 | Calculated using Price: 3.19 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 27.69 Cr. | 276,859,850 Shares |
| FaceValue | 1 | |
| About Genpharmasec Ltd. | ||
| Adi Rasayan Limited was incorporated as Public Limited Company on November 16, 1992 and obtained Commencement of Business Certificate on November 20, 1992 with the object, of manufacturing and trading in organic and inorganic chemicals dyes and pigments. The company was promoted by Sanjay J. Adani, Dinesh H. Desai, Dahyabhai Patel, Vikram R. Shah and Mitesh J. Adani and family members. | ||
| 1 Day |
|
-0.31% |
| 1 Week |
|
-0.62% |
| 1 Month |
|
+2.25% |
| 3 Month |
|
-16.09% |
| 6 Month |
|
-23.19% |
| 1 Year |
|
-36.27% |
| 2 Year |
|
-62.68% |
| 5 Year |
|
-32.34% |
| 10 Year |
|
+119.31% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 2.40 | 5.36 | 7.81 | -1.39 | ||||||
| Return on Capital Employed (%) | 79.54 | 61.73 | 188.97 | 13.56 | 48.58 | 2.65 | 5.93 | 7.61 | -2.46 | |
| Return on Assets (%) | 4.72 | 16.55 | 169.79 | 4.73 | 12.76 | 2.12 | 4.35 | 4.78 | -0.85 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | -1 | -1 | -1 | -1 | -1 | 22 | 19 | 21 | 15 | 14 | |
| Non Curr. Liab. | 1 | 1 | 1 | 1 | 1 | ||||||
| Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 6 | 7 | 6 | 5 | ||
| Minority Int. | |||||||||||
| Equity & Liab. | 0 | 0 | 0 | 1 | 0 | 22 | 25 | 28 | 22 | 19 | |
| Non Curr. Assets | 14 | 9 | 1 | 0 | 0 | ||||||
| Curr. Assets | 0 | 0 | 0 | 1 | 0 | 8 | 16 | 27 | 22 | 19 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 0 | 0 | 0 | 1 | 0 | 22 | 25 | 28 | 22 | 19 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 0 | 0 | 0 | 0 | 17 | 21 | 27 | 27 | |||
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Total Income | 0 | 0 | 0 | 1 | 0 | 1 | 17 | 22 | 27 | 27 | |
| Total Expenditure | 0 | 0 | 0 | -1 | 0 | 0 | -16 | -20 | -28 | -27 | |
| PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | |
| Interest | |||||||||||
| Depreciation | 0 | 0 | 0 | ||||||||
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Exceptional Items | 0 | ||||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | |
| Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | -6 | 1 | -2 | -2 | |
| Cash Fr. Inv. | 0 | -10 | -4 | -1 | 0 | ||||||
| Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 22 | 5 | ||||
| Net Change | 0 | 0 | 0 | 0 | 0 | 5 | -3 | 1 | -2 | ||
| Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 3 | 4 | 2 |
|
Fri, 26 May 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 26Th May 2023 1. Considered & Approved the Audited Financial Results (Standalone) for the quarter and year ended 31.03.2023. (Enclosed);2. Considered & Approved the Audit Report (Standalone) issued by M/S. Abhishek S Tiwari & Associates Chartered Accountant Statutory Auditors of the Company in as per Regulation 33 of SEBI (LODR) Regulations 2015 for the quarter and year ended 31.03.2023. (Enclosed)along with the declaration that the Report of Statutory Auditors is with unmodified opinion with respect to Standalone Audited Financial Results for the Quarter and year ended 31st March 2023 is attached herewith.3. The appointment of M/ s. Jaymin Modi & Co Practicing Company Secretary as the Secretarial Auditor of the Company for financial year 2023-2024.4. The appointment of M/ s. Meenakshi Manish Jain & Associates Chartered Accountants as an Internal Auditor of the Company for financial year 2023-2024. |
|
Fri, 26 May 2023
For The Year Ended March 31 2023 1. Considered & Approved the Audited Financial Results (Standalone) for the quarter and year ended 31.03.2023. (Enclosed); 2. Considered & Approved the Audit Report (Standalone) issued by M/S. Abhishek S Tiwari & Associates Chartered Accountant Statutory Auditors of the Company in as per Regulation 33 of SEBI (LODR) Regulations 2015 for the quarter and year ended 31.03.2023. (Enclosed)along with the declaration that the Report of Statutory Auditors is with unmodified opinion with respect to Standalone Audited Financial Results for the Quarter and year ended 31st March 2023 is attached herewith. 3. The appointment of M/ s. Jaymin Modi & Co Practicing Company Secretary as the Secretarial Auditor of the Company for financial year 2023-2024. 4. The appointment of M/ s. Meenakshi Manish Jain & Associates Chartered Accountants as an Internal Auditor of the Company for financial year 2023-2024. |
|
Thu, 18 May 2023
Board Meeting Intimation for Meeting Of Directors To Be Held On 26Th May 2023 For Declaration Of Audited Financial Results Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2023 inter alia to consider and approve 1. To consider & approve the Audited Financial Results along with the Limited Review Report Statement of Assets and Liabilities and Cash flow Statement for the Quarter and Financial Year ended on March 31 20232. To consider and Approve the Audited Statement of Assets and Liabilities for the year ended 31st March 2023.3. To confirm Closure of trading window from 03rd April 2023 till the end of 48 hours as per the Sebi (Prohibition of Insider Trading) Regulations 2015 for Directors and Designated Employees as defined in the "Code of Conduct for Prevention of Insider Trading of the Company.4. Appointment of M/s. Jaymin Modi & Co. Practicing Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2023-2024.5. Appointment of M/s. Meenakshi Manish Jain & Associates Practicing Chartered Accountants as the Internal Auditor of the Company for the Financial Year 2023-2024.6. Any other business matter with the permission of the Chair. |
| Fri, 26 May 2023 |
High Delivery Percentage
|
High Decrease in 3 Months
|
High Decrease in 6 Months
|
High Decrease in 1 Year
|
High Decrease in 2 Years
|
Equities
M.F.
Sectors
StockEdge Social